Prevention of anti-competitive conduct, prevention of money laundering... The optimal way to address each of these issues is in a specific way. Integral and not in a fragmented way. The aforementioned elements constitute the parts of a whole, so by carrying out this comprehensive approach we can avoid overlaps and inconsistencies that minimize the effectiveness of the operations. To develop effective pharmaceutical compliance, it is crucial to coordinate the different compliance blocks.
Those standards voluntarily assumed by companies codes of good practice, ethical codes, internal policies, etc. The pharmaceutical field is especially sensitive when it comes to moral issues. Being focused on health, a series of questions are raised such as whatsapp number list global access to medicines, the establishment of prices, pharmaceutical development in rare or low-incidence diseases... The approach that each pharmaceutical industry proposes on these issues, will largely determine its evolution and development, so it is important to monitor and control it properly. Another particularity that pharmaceutical compliance presents is the market model that this industry presents.
The pharmaceutical market is the only one where the consumer cannot directly access the product, since it must be subject to the prior prescription of a doctor, and this means that it has certain particularities and that, on occasions, certain types of unethical practices are encouraged. . A very representative example of the practices that pharmaceutical compliance must avoid and prevent is bribery of prescribing physicians. In no case can a medical representative be allowed to offer any type of compensation to a doctor for prescribing